Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04145843 · ClinicalTrials.gov registry record
Treatment Outcomes in Bile Duct Stones
A clinical trial, sponsored by AdventHealth.
- Completed
- Registry status
- 42
- Enrollment target
NCT04145843: Completed study, sponsored by AdventHealth.
NCT04145843 is a clinical trial that has completed, run by AdventHealth. The registered enrollment target is 42 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04145843 has completed, sponsored by AdventHealth.
- COMPLETED
- Registry status
- 42 participants
- Enrollment target
Study Summary
This registry is to evaluate the procedural and clinical outcomes in patients undergoing endoscopic treatment of bile duct stones when utilizing an algorithmic management approach.
Primary Outcome
Percent of patients that achieve ductal clearance at the index intervention
Interventions
- PROCEDURE endoscopic retrograde cholangiopancreatography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2019-11-06 |
| Est. Completion | 2022-04-05 |
What the finished NCT04145843 record still lists
NCT04145843 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 42 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which endoscopic retrograde cholangiopancreatography is the first listed.
NCT04145843 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04145843 about?
NCT04145843 is a clinical study titled "Treatment Outcomes in Bile Duct Stones". This registry is to evaluate the procedural and clinical outcomes in patients undergoing endoscopic treatment of bile duct stones when utilizing an algorithmic management approach.
What is the current status of trial NCT04145843?
This trial is currently completed. The enrollment target is 42 participants. The study started on 2019-11-06. Estimated completion is 2022-04-05.
What interventions are being tested in trial NCT04145843?
The interventions under investigation include: endoscopic retrograde cholangiopancreatography (PROCEDURE).
Who is sponsoring clinical trial NCT04145843?
This trial is sponsored by AdventHealth, which has 95 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02852213 · 42 participants · Phase 1
A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients
- NCT03136146 · 42 participants · Phase 2
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
- NCT03178149 · 42 participants · Phase 1
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- NCT03663530 · 42 participants · NA
Circadian Misalignment and Energy Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI